t, a molecule called mTOR, is a protein that influences a cell's ability to expand in size. mTOR has been widely studied as the target for the immunosuppressant drug rapamycin (in fact, mTOR is an acronym for "mammalian target of rapamycin"). In July of 2004, Dos Sarbassov, a scientist in Sabatini's lab, discovered a new protein that mTOR interacts with called rictor, but he wasn't yet sure of what these two proteins do together. In this latest paper, Sarbassov reports that when mTOR and rictor bind and form a complex, they help activate Akt by adding a phosphate group to a sequence of its amino acids (a process called "phosphorylation").
This process occurs not only in human cells but in other organisms such as the fruit fly. Finding this complex conserved in species as diverse as flies and humans supports the claim that the mTOR/rictor complex is indeed a missing piece of the puzzle.
According to Sarbassov, "If we find a molecule that can block the mTOR/rictor complex, then we may be able to prevent Akt from becoming active and contributing to tumor formation."
'"/>Source:
Whitehead Institute for Biomedical Research
Page: 1 2 Related biology news :1.
Researchers discover way to make cells in the eye sensitive to light2.
Researchers find how protein allows insects to detect and respond to pheromones3.
Researchers Uncover Key Step In Manufacture of Memory Protein4.
Researchers reveal the infectious impact of salmon farms on wild salmon5.
Researchers discover molecule that causes secondary stroke6.
Researchers find missing genes of ancient organism7.
Researchers trace evolution to relatively simple genetic changes8.
Researchers add new tool to tumor-treatment arsenal9.
UF Researchers Map Bacterial Proteins That Cause Tooth Loss10.
VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain11.
Researchers develop rapid diagnostic tool for pathogen identification